靶向基因组测序发现CAV1罕见变异与阻塞性睡眠呼吸暂停相关
研究利用TOPMed高深度测序和多个群体基因型数据,在7,708名欧洲裔个体中分析呼吸暂停低通气指数(AHI)。在CAV1基因发现21个非编码罕见变异与较低AHI相关(P=7.4×10⁻⁸),且这些变异与CAV1表达升高相关,外周单核细胞CAV1表达升高与较低AHI(P=0.024)和较高夜间最低血氧饱和度(P=0.007)相关。
要点
- CAV1非编码罕见变异与较低AHI相关,提示对OSA严重程度有保护作用。
- 这些变异与CAV1表达升高相关,外周单核细胞CAV1表达升高与较低AHI和较高夜间最低血氧饱和度相关。
- CAV1可能成为调节OSA严重程度的新靶点。
核心结论
- CAV1罕见变异与CAV1基因表达升高及较低OSA严重程度相关,提示CAV1是调节OSA严重程度的潜在新靶点。
研究设计与样本
- 利用NHLBI TOPMed项目高深度基因组测序数据和多个群体研究的基因型填补数据,在Cleveland家庭研究(CFS)中进行连锁分析,随后在独立队列中对7,708名欧洲裔个体的AHI进行多阶段基于基因的关联分析。
主要发现
- 在CFS连锁分析中发现7q31染色体提示性连锁峰(LOD=2.31)。
- 基于基因分析鉴定出CAV1基因21个非编码罕见变异与较低AHI相关,校正多重比较后P=7.4×10⁻⁸。
- 这些非编码变异共同显著贡献于连锁证据(P<10⁻³)。
- 随访分析显示这些变异与CAV1表达升高显著相关。
- 外周单核细胞CAV1表达升高与较低AHI(P=0.024)和较高夜间最低血氧饱和度(P=0.007)相关。
关键数值与推荐
- CAV1基因21个非编码罕见变异与较低AHI相关,P=7.4×10⁻⁸。
- 这些变异共同贡献连锁证据,P<10⁻³。
- 外周单核细胞CAV1表达升高与较低AHI相关,P=0.024。
- 外周单核细胞CAV1表达升高与较高夜间最低血氧饱和度相关,P=0.007。
临床怎么用
- CAV1罕见变异及表达水平可能作为评估OSA严重程度的遗传标志物,但尚需临床验证。
- CAV1通路可能为调节OSA严重程度提供新靶点,但尚无干预性研究支持临床应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Obstructive sleep apnea (OSA) is a common disorder associated with increased risk for cardiovascular disease, diabetes, and premature mortality. There is strong clinical and epidemiologic evidence supporting the importance of genetic factors influencing OSA but limited data implicating specific genes. Objectives: To search for rare variants contributing to OSA severity. Methods: Leveraging high-depth genomic sequencing data from the NHLBI Trans-Omics for Precision Medicine (TOPMed) program and imputed genotype data from multiple population-based studies, we performed linkage analysis in the CFS (Cleveland Family Study), followed by multistage gene-based association analyses in independent cohorts for apnea-hypopnea index (AHI) in a total of 7,708 individuals of European ancestry. Measurements and Main Results: Linkage analysis in the CFS identified a suggestive linkage peak on chromosome 7q31 (LOD = 2.31). Gene-based analysis identified 21 noncoding rare variants in CAV1 (Caveolin-1) associated with lower AHI after accounting for multiple comparisons (P = 7.4 × 10-8). These noncoding variants together significantly contributed to the linkage evidence (P < 10-3). Follow-up analysis revealed significant associations between these variants and increased CAV1 expression, and increased CAV1 expression in peripheral monocytes was associated with lower AHI (P = 0.024) and higher minimum overnight oxygen saturation (P = 0.007). Conclusions: Rare variants in CAV1, a membrane-scaffolding protein essential in multiple cellular and metabolic functions, are associated with higher CAV1 gene expression and lower OSA severity, suggesting a novel target for modulating OSA severity.
引用
- Liang J, Wang H, Cade BE, et al. Targeted Genome Sequencing Identifies Multiple Rare Variants in Caveolin-1 Associated with Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2022. PMID: 35822943. doi:10.1164/rccm.202203-0618OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。